Telesis Bio Inc.

TBIOCIK 0001850079 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K filed Mar 29, 2024. Sentiment + YoY language diff vs prior year. Read sections →

Signal:Material rewriteFull-doc fallback

Full filing:tone -0.0164Δ-0.004210% similar+1734/-86 ¶

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Nov 8, 2024no items parsed Oct 25, 2024no items parsed Sep 10, 2024no items parsed Aug 30, 2024no items parsed Aug 28, 2024no items parsed

YoY shift: Lean -

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is -0.42pp more bearish than last year's.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Telesis Bio Inc.

Name	Roles	Filings
Nelson Todd Robert	OfficerDirector10% Owner	5
Gibson Daniel Glenn	Officer	4
Cutler Rob	Officer	3
Esser Eric Eugene	OfficerDirector	3
Herrema Gregory J.	Director	2

Showing 1-5 of 24

Per pagePage 1 of 5Next

All filings

39 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
May 3, 2024	Herrema Gregory J. Director	AGrant	31,486	$0.00	$0

Filed		Top transaction	Shares	Price	Value